T. Rowe Price Associates’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Buy |
21,517
+1,327
| +7% | +$7.15K | ﹤0.01% | 2863 |
|
|
2025
Q1 | $108K | Buy |
20,190
+2,428
| +14% | +$13K | ﹤0.01% | 2803 |
|
|
2024
Q4 | $159K | Buy |
17,762
+2,878
| +19% | +$25.8K | ﹤0.01% | 2747 |
|
|
2024
Q3 | $164K | Hold |
14,884
| – | – | ﹤0.01% | 2712 |
|
|
2024
Q2 | $136K | Buy |
14,884
+681
| +5% | +$6.22K | ﹤0.01% | 2692 |
|
|
2024
Q1 | $200K | Buy |
+14,203
| New | +$200K | ﹤0.01% | 2623 |
|
|
2021
Q4 | – | Sell |
-11,966
| Closed | -$106K | – | 2981 |
|
|
2021
Q3 | $106K | Sell |
11,966
-1
| -0% | -$9 | ﹤0.01% | 2827 |
|
|
2021
Q2 | $151K | Sell |
11,967
-238
| -2% | -$3K | ﹤0.01% | 2775 |
|
|
2021
Q1 | $212K | Buy |
+12,205
| New | +$212K | ﹤0.01% | 2666 |
|